Li Ma
Impact in
- Cancer Research top 0.05%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 0.2%
- RNA modifications and cancer
- Circular RNAs in diseases
- PI3K/AKT/mTOR signaling in cancer
- RNA Research and Splicing
- Epigenetics and DNA Methylation
Papers in
-
- RNA modifications and cancer 28
- Ubiquitin and proteasome pathways 15
- Epigenetics and DNA Methylation 14
- RNA Research and Splicing 12
-
- Cancer-related molecular mechanisms research 24
- MicroRNA in disease regulation 21
- Co-authors
- Julie Teruya‐Feldstein (10 shared papers)Robert A. Weinberg (7 shared papers)Yutong Sun (31 shared papers)Pier Paolo Pandolfi (7 shared papers)Zhenbang Chen (2 shared papers)Hediye Erdjument‐Bromage (1 shared paper)Paul Tempst (1 shared paper)Jongchan Kim (11 shared papers)
- Journals
- Nature Communications (9 papers)Cancer Research (7 papers)Cancers (6 papers)Nature Cell Biology (6 papers)Biochemical and Biophysical Research Communications (5 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Li Ma
255 papers receiving 18.5k citations
Li Ma's Hit Papers
Peers
Comparison fields: 5 of 163
- Cancer Research 6.9k
- Molecular Biology 12.3k
- Oncology 2.6k
- Immunology 1.4k
- Genetics 666
Countries citing papers authored by Li Ma
This map shows the geographic impact of Li Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Ma more than expected).
Fields of papers citing papers by Li Ma
This network shows the impact of papers produced by Li Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Ma. The network helps show where Li Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Li Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 264 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tumour invasion and metastasis initiated by microRNA-10b in breast cancer Hit paper breakdown → | 2007 | 2112 |
| 2 | Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer Hit paper breakdown → | 2008 | 1149 |
| 3 | miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis Hit paper breakdown → | 2010 | 1111 |
| 4 | Phosphorylation and Functional Inactivation of TSC2 by Erk Hit paper breakdown → | 2005 | 1043 |
| 5 | Energy-stress-mediated AMPK activation inhibits ferroptosis Hit paper breakdown → | 2020 | 885 |
| 6 | Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model Hit paper breakdown → | 2010 | 610 |
| 7 | Long noncoding RNA MALAT1 suppresses breast cancer metastasis Hit paper breakdown → | 2018 | 557 |
| 8 | ZEB1: At the crossroads of epithelial-mesenchymal transition, metastasis and therapy resistance Hit paper breakdown → | 2015 | 471 |
| 9 | 2004 | 469 | |
| 10 | Metabolic reprogramming during neuronal differentiation from aerobic glycolysis to neuronal oxidative phosphorylation Hit paper breakdown → | 2016 | 466 |
| 11 | 2016 | 378 | |
| 12 | 2007 | 368 | |
| 13 | 2014 | 358 | |
| 14 | 2012 | 355 | |
| 15 | YTHDF3 Induces the Translation of m6A-Enriched Gene Transcripts to Promote Breast Cancer Brain Metastasis Hit paper breakdown → | 2020 | 306 |
| 16 | 2015 | 266 | |
| 17 | 2019 | 233 | |
| 18 | 2012 | 233 | |
| 19 | 2019 | 220 | |
| 20 | 2007 | 218 |
About Li Ma
Li Ma is a scholar working on Molecular Biology, Cancer Research, Oncology, Immunology and Hematology, having authored 264 papers that have together received 18.7k indexed citations. Recurring topics across this work include RNA modifications and cancer (28 papers), Cancer-related molecular mechanisms research (24 papers), MicroRNA in disease regulation (21 papers), Platelet Disorders and Treatments (17 papers), Ubiquitin and proteasome pathways (15 papers), Epigenetics and DNA Methylation (14 papers), Cancer-related Molecular Pathways (13 papers) and RNA Research and Splicing (12 papers). The work is most often cited by research in Cancer Research (6.9k citations), Molecular Biology (12.3k citations), Oncology (2.6k citations), Immunology (1.4k citations) and Genetics (666 citations). Li Ma has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Julie Teruya‐Feldstein, Robert A. Weinberg, Yutong Sun, Pier Paolo Pandolfi, Zhenbang Chen, Hediye Erdjument‐Bromage, Paul Tempst, Jongchan Kim, Ferenc Reinhardt and Elizabeth Pan. Their work appears in journals such as Nature Communications, Cancer Research, Cancers, Nature Cell Biology and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.